Cura Therapeutics
PrivateLast Round
Accelerator
Nov 25, 2025
Total Funding Raised
$125,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cura Therapeutics operates in Healthcare & Life Sciences and is based in Montreal, Quebec. Its latest recorded funding round was an Accelerator round in November 2025.
Cura Therapeutics is a biotechnology company developing multimodal immunotherapies to treat metastatic cancers, pathogen infections, and age-associated diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cura Therapeutics Comparables
Compare Cura Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ability Biotherapeutics | 73% | |
| Xilio Therapeutics | 71% | |
| Synthekine | 70% |
For institutional investors. Book with your work email.
Cura Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Nov 25, 2025 | ||||
| Accelerator | Mar 6, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cura Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ontario Bioscience Innovation Organization | Accelerator |
| Capital BioVentures | Accelerator |
| FACIT | Accelerator, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 145% MoM.
- May 2, 2025
Monthly visitors grew 116% MoM.
For institutional investors. Book with your work email.
Cura Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cura Therapeutics's valuation, stock price, and market status.
Is Cura Therapeutics a public or private company?
Cura Therapeutics is a private company.
What is the current stock price of Cura Therapeutics?
Cura Therapeutics is a private company, so its shares have no public market price. Caplight tracks Cura Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cura Therapeutics worth (valuation)?
Valuation information for Cura Therapeutics is not publicly available.
Can I buy Cura Therapeutics stock?
Cura Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cura Therapeutics's last funding round?
Cura Therapeutics's most recent funding round was Accelerator on November 25, 2025.
Who are the main investors in Cura Therapeutics?
Key investors in Cura Therapeutics include Capital BioVentures, FACIT.
Will Cura Therapeutics IPO soon?
No public IPO plans have been announced for Cura Therapeutics.
How can I track Cura Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Cura Therapeutics's shares on secondary markets.